Frazier Lifesciences Acquisition Statistics Share Statistics Frazier Lifesciences Acquisition has n/a
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 16.49K, so 0% of the outstanding
shares have been sold short.
Short Interest 16.49K Short % of Shares Out n/a Short % of Float 0.13% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 17.77 and the forward
PE ratio is null.
Frazier Lifesciences Acquisition's PEG ratio is
0.
PE Ratio 17.77 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 1.31 P/FCF Ratio -1250.72 PEG Ratio 0
Financial Ratio History Enterprise Valuation Frazier Lifesciences Acquisition has an Enterprise Value (EV) of 171.85M.
EV / Sales 0 EV / EBITDA 40.96 EV / EBIT -1241.86 EV / FCF -1241.86
Financial Position The company has a current ratio of 6.7,
with a Debt / Equity ratio of 0.
Current Ratio 6.7 Quick Ratio 6.7 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -84.54
Financial Efficiency Return on Equity is 7.4% and Return on Invested Capital is -2.29%.
Return on Equity 7.4% Return on Assets 6.98% Return on Invested Capital -2.29% Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -5.56M Effective Tax Rate -133.07%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Frazier Lifesciences Acquisition's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 9.96 200-Day Moving Average n/a Relative Strength Index (RSI) 48.7 Average Volume (20 Days) 185,000
Income Statement
Revenue n/a Gross Profit n/a Operating Income -1.37M Net Income 9.74M EBITDA 4.2M EBIT 4.2M Earnings Per Share (EPS) 0.55
Full Income Statement Balance Sheet The company has 1.23M in cash and 0 in
debt, giving a net cash position of 1.23M.
Cash & Cash Equivalents 1.23M Total Debt n/a Net Cash n/a Retained Earnings -6.36M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -138.38K
and capital expenditures 0, giving a free cash flow of -138.38K.
Operating Cash Flow -138.38K Capital Expenditures n/a Free Cash Flow -138.38K FCF Per Share -0.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
